Solo Jonas brother carries Merz's new tune in Botox rival campaign

Nicole DeFeudis

Editor

As the lyrics of his band’s 2019 pop-rock single suggest, Joe Jonas is only human — and that means even he gets frown lines. The 33-year-old singer-songwriter is Merz’s newest celebrity brand partner for its Botox rival Xeomin, as medical aesthetics brands target a younger audience.

Merz kicked off its “Beauty on Your Terms” campaign on Tuesday, featuring the Jonas brother in a video ad for its double-filtered anti-wrinkle injection Xeomin.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

BECOME A PREMIUM SUBSCRIBER

TRENDING NOW

Solo Jonas brother carries Merz's new tune in Botox rival campaign

Nicole DeFeudis

Editor

Unlock this article instantly by becoming a free subscriber.

In one of JP Morgan's first biotech bets, Enlaza raises $100M for its permanently binding protein drugs

Lilly boosts sales guidance by $2B, but GLP-1 supply constraints still a focus

Federal judge throws out two drugmaker IRA lawsuits in win for government

Novartis hands PeptiDream $180M upfront to extend radiopharma discovery pact

DNA sequencing firm PacBio to lay off workers and shutter San Diego office

A New Precision Approach for Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

So­lo Jonas broth­er car­ries Merz's new tune in Botox ri­val cam­paign

Nicole DeFeudis

Editor

Unlock this article instantly by becoming a free subscriber.

In one of JP Mor­gan's first biotech bets, En­laza rais­es $100M for its per­ma­nent­ly bind­ing pro­tein drugs

Lil­ly boosts sales guid­ance by $2B, but GLP-1 sup­ply con­straints still a fo­cus

Fed­er­al judge throws out two drug­mak­er IRA law­suits in win for gov­ern­ment

No­var­tis hands Pep­tiDream $180M up­front to ex­tend ra­dio­phar­ma dis­cov­ery pact

DNA se­quenc­ing firm PacBio to lay off work­ers and shut­ter San Diego of­fice

A New Pre­ci­sion Ap­proach for Non-Small Cell Lung Can­cer with EGFR Ex­on 20 In­ser­tion Mu­ta­tions

Solo Jonas brother carries Merz's new tune in Botox rival campaign

In one of JP Morgan's first biotech bets, Enlaza raises $100M for its permanently binding protein drugs

Lilly boosts sales guidance by $2B, but GLP-1 supply constraints still a focus

Federal judge throws out two drugmaker IRA lawsuits in win for government

Novartis hands PeptiDream $180M upfront to extend radiopharma discovery pact

DNA sequencing firm PacBio to lay off workers and shutter San Diego office

A New Precision Approach for Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations